News

News

Press Releases | Publications | In the News

Press Releases

Press releases

February 9, 2023
Ensoma Announces Closing of Twelve Bio Acquisition
January 5, 2023
Ensoma Announces $85 Million Financing and Agreement to Acquire Twelve Bio to Advance Portfolio of In Vivo Engineered Cellular Medicines
October 28, 2021
Ensoma Strengthens Scientific Advisory Board with Leaders in Oncology and Primary Immune Deficiencies
October 11, 2021
Ensoma Appoints Cell and Gene Therapy Pioneer Emile Nuwaysir, Ph.D., as Chief Executive Officer
February 11, 2021
Ensoma Announces Strategic Collaboration with Takeda to Accelerate Next-Generation In Vivo Gene Therapies
February 11, 2021
Ensoma Launches to Pioneer Next-Generation In Vivo Approach to Deliver First “Off-the-shelf” Genomic Medicines
Publications

Publications

JCI Insight | August 25, 2022
In vivo base editing by a single intravenous vector injection for treatment of hemoglobinopathies
Blood Advances | July 29, 2022
In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4
Blood Advances | February 23, 2021
In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal γ-globin in β-YAC mice
Molecular Therapy | September 5, 2020
In vivo HSC gene therapy using a bi-modular HDAd5/35++ vector cures sickle cell disease in a mouse model
JCI Insight | August 20, 2020
Curative in vivo hematopoietic stem cell gene therapy of murine thalassemia using large regulatory elements
Molecular Therapy | December 4, 2019
Targeted integration and high-level transgene expression in AAVS1 transgenic mice after in vivo HSC transduction with HDAd5/35++ vectors
In the News

In the news

BioPharma Dive | October 18, 2022
‘In vivo’ cell therapy: expanding beyond CAR-T
Nature Biotechnology | August 26, 2022
Ensoma and Interius BioTherapeutics: in vivo veritas
Biotech 2050 Podcast | May 6, 2022
Revolutionizing genetic medicine, Paula Soteropoulos, Chairman of the Board, Ensoma
Boston Business Journal | April 19, 2022
Best Places to Work honorees announced — Small category
BioCentury | February 2, 2022
BioCentury’s 2021 class of emerging companies
BioSpace | January 6, 2022
Top Life Sciences Startups to Watch in 2022

Like what you see?
Join our team.

See our current opportunities